Icon Lab expands Irish facilities to meet demand

By Emilie Reymond

- Last updated on GMT

Related tags: Medicine

Icon Laboratories, a provider of outsourced services for the
biopharma industry, has expanded its central lab facilities in
Ireland by 30 per cent to meet growing demand for clinical trial
testing services.

The newly redesigned laboratory, located in Dublin, also doubles the size of the operational facilities supporting project management and global logistics services.

The US-based company provides safety testing and biomarker measurements for clinical trials, mainly phase II and III, and the $1.5m (€1.2m) investment to enlarge its Dublin laboratory will allow the firm to further develop its flow cytometry technology, particularly useful in the development of oncology therapies.

There has been a growing demand for such services, particularly due to the host of new oncology, infectious disease and immunology therapies coming through the pipelines.

"Over the last five years, more and more drug makers have been outsourcing these tests to central laboratories such as ours,"​ Robert Scott-Edwards, president of Icon Laboratories, told Labtechnologist.com.

"This expansion is part of Icon's efforts to ensure that it can respond to significant global growth in customer base and volume of clinical trials."

The expanded facilities are also part of a wider capacity development being employed by the global firm who is also planning the launch of a new lab facility in Singapore at the end of the year.

"The Asian market is a very important market,"​ said Scott-Edwards.

"We already work in the Asian market in collaboration with partners but we wanted to have our own facilities."

Icon Laboratories, which had a growth rate of 60 per cent in the past year, provides services for 90 pharma and biotech companies in 52 countries.

Related news

Show more

Related products

show more

Has EDC Kept Up With Changes In Clinical Trials?

Has EDC Kept Up With Changes In Clinical Trials?

Oracle Health Sciences | 14-Dec-2020 | Technical / White Paper

In just a few decades, clinical trials have changed dramatically. Twenty years ago, most of the data used in clinical research was entered on paper, but...

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

CAR-T Cell Therapy

CAR-T Cell Therapy

Q² Solutions | 01-Sep-2020 | Clinical Study

Cell therapy involves the transfer of genetically altered cells into a patient. As a global central laboratory services organization, we provide testing...

Related suppliers

Follow us


View more